ACER THERAPEUTICS
Acer Therapeutics is a pharmaceutical company that focuses on the acquisition, development, and commercialization of therapies for serious rare, and life-threatening diseases with critical unmet medical needs. Its pipeline includes four clinical-stage candidates: emetine hydrochloride for the treatment of patients with COVID-19; ACER-001 (a taste-masked, immediate-release formulation of sodium phenylbutyrate), for the treatment of various inborn errors of metabolism, including urea cycle disorde... rs (UCDs) and Maple Syrup Urine Disease (MSUD); EDSIVO™ (celiprolol), for the treatment of vascular Ehlers-Danlos syndrome (vEDS) in patients with a confirmed type III collagen (COL3A1) mutation; and osanetant, for the treatment of induced Vasomotor Symptoms (iVMS). The company was founded in 2013 and is headquartered in Newton, Massachusetts.
ACER THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2013-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.acertx.com
Total Employee:
11+
Status:
Active
Total Funding:
74.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Athenex
Athenex is a biopharmaceutical company that develops and discovers novel therapies for treating cancer and related conditions.
Pliant Therapeutics
Pliant Therapeutics focuses on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-09-19 | Opexa Therapeutics | Opexa Therapeutics acquired by Acer Therapeutics | N/A |
Investors List
SWK Holdings
SWK Holdings investment in Post-IPO Debt - Acer Therapeutics
Marathon Asset Management
Marathon Asset Management investment in Post-IPO Debt - Acer Therapeutics
TVM Capital Life Science
TVM Capital Life Science investment in Post-IPO Equity - Acer Therapeutics
TVM Capital Life Science
TVM Capital Life Science investment in Post-IPO Equity - Acer Therapeutics
Key Employee Changes
Official Site Inspections
http://www.acertx.com Semrush global rank: 8.8 M Semrush visits lastest month: 254
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Acer Therapeutics"
Acer Therapeutics Inc. | LinkedIn
Acer Therapeutics Inc. (Nasdaq: ACER) is a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with ...See details»
Position Profile - Acer Therapeutics
Www.acertx.com. March 2021 . 2 . Company Overview . We are a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare …See details»
Corporate Presentation - Acer Therapeutics
Jun 26, 2023 Symptoms of Hyperammonemia General – Growth retardation – Hypothermia Central – Combativeness – Lethargy – Coma Eyes – Papilledema Pulmonary Shortness of …See details»
Acer Therapeutics Inc (ACER) Profile - The Globe and Mail
See the company profile for Acer Therapeutics Inc (ACER) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
November 2020 Nasdaq: ACER - Acer Therapeutics
Nov 10, 2020 Corporate Overview. Acer Therapeutics is a pharmaceutical company that acquires, develops and seeks to commercialize therapies for serious rare and life-threatening …See details»
Acer Therapeutics Company Profile | Management and Employees …
Www.acertx.com Acer Therapeutics Profile and History Founded in 2013, Acer Therapeutics Inc. develops re-purposed and reformulated medicines to treat ultra-orphan diseases.See details»
Acer Therapeutics Inc. - Cruelty Free Investing
Acer Therapeutics Inc., a pharmaceutical company, develops therapies for the treatment of rare diseases with critical unmet medical needs. Its product candidates include Celiprolol for the …See details»
Acer Therapeutics - Craft
Jul 18, 2024 Acer Therapeutics is a pharmaceutical company that focuses on the acquisition, development, and commercialization of therapies. Its product candidates include: ACER-001 …See details»
Acer Therapeutics - Overview, News & Similar companies
Aug 31, 2023 ACER Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Acer Therapeutics Inc. Is Fair to Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh …See details»
www.acertx.org
Www.acertx.orgSee details»
Acer Therapeutics Announces Initiation of its Pivotal …
Jun 28, 2022 Data from these and other publications can be found at www.acertx.com. Acer’s original NDA was submitted based on data obtained from the BBEST trial and accepted for filing in October 2018 with priority review. …See details»
Acertx.com Home - Acer Therapeutics - HypeStat
Acertx.com uses CloudFlare, Contact Form 7, cdnjs, Font Awesome, Google Analytics, Gravity Forms, HTTP/3, Hammer.js, jQuery, jQuery Migrate, jQuery Modal, Modernizr ...See details»
Acer Therapeutics Announces Initiation of its Pivotal Phase 3 …
NEWTON, Mass., June 27, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a clinical stage pharmaceutical company focused on the acquisition, development and …See details»
Acer Therapeutics to Participate in March Virtual Investor …
Mar 1, 2021 For more information, visit www.acertx.com. Investor Contact:Hans VitzthumLifeSci AdvisorsPh: [email protected] Jim DeNikeAcer Therapeutics Inc.Ph: …See details»
Vice President, Market Access & Reimbursement - Acer Therapeutics
Www.acertx.com September 2021 . 2 Company Overview We are a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare …See details»
ACER THERAPEUTICS INC. NOMINATING AND CORPORATE …
Page 1 of 3 4832-9432-9710.v3 . ACER THERAPEUTICS INC. _____ NOMINATING AND CORPORATE GOVERNANCE CHARTER (effective April 15, 2022)See details»
What is website location for domain Acertx.com? - IP-Tracker.org
IP Tracker » IP Lookup » Acertx.com What is website location for domain Acertx.com? Our tracking system has found a website location for the domain Acertx.com at latitude 34.1473 …See details»
Acer Therapeutics Reacquires Worldwide Development,
Aug 30, 2023 [email protected] +1-844-902-6100. Nick Colangelo Gilmartin Group [email protected] +1-332-895-3226 ...See details»
Garantex Cryptocurrency Exchange Disrupted in International …
Mar 7, 2025 Garantex Splash Page. In conjunction with the operation targeting Garantex, the Department also announced the unsealing of an indictment in the Eastern District of Virginia …See details»
August 23, 2022 Nasdaq: ACER - Acer Therapeutics
Aug 23, 2022 Corporate Overview. Acer Therapeutics is a pharmaceutical company that acquires, develops and seeks to commercialize therapies for serious rare and life-threatening …See details»